脂蛋白(a)联合TyG指数对冠心病合并 2型糖尿病患者首次PCI术后非致命性 心肌梗死的预测价值
Predictive Value of Lipoprotein(a) Combined with TyG Index for Non-Fatal Myocardial Infarction after First PCI in Patients with Coronary Heart Disease Complicated with Type 2 Diabetes
DOI: 10.12677/acm.2026.162571, PDF,   
作者: 陈 雪:青岛大学附属医院心血管内科,山东 青岛;黄岛区中医医院健康管理科,山东 青岛;李 健*:青岛大学附属医院心血管内科,山东 青岛
关键词: 冠心病2型糖尿病PCI脂蛋白(a)TyG指数预测Coronary Heart Disease Type 2 Diabetes Percutaneous Coronary Intervention Lipoprotein(a) Triglyceride-Glucose Index Prediction
摘要: 目的:探究脂蛋白(a) (lipoprotein(a), Lp(a))联合甘油三酯–葡萄糖指数(triglyceride-glucose index, TyG)对冠心病(coronary heart disease, CHD)合并2型糖尿病(type 2 diabetes mellitus, T2DM)患者首次经皮冠状动脉介入(percutaneous coronary intervention, PCI)术后非致命性心肌梗死的预测价值。方法:回顾性分析2020年1月至2023年1月首次在青岛大学附属医院接受PCI术治疗的586例CHD合并T2DM患者的临床资料,对患者进行术后随访并记录非致命性心肌梗死发生情况。根据术后是否发生非致命性心肌梗死,将患者分为非致命性心梗组(n = 115)和无非致命性心梗组(n = 471)。比较两组患者强效他汀使用率;采用Bootstrap重抽样法(重抽样1000次)校正ROC曲线的AUC及95%置信区间以验证模型稳定性;同时纳入糖化血红蛋白(HbA1c)作为对照指标。采用多因素Cox比例风险回归模型分析术后发生非致命性心肌梗死的危险因素,绘制受试者工作特征(receiver operating characteristic, ROC)曲线并计算曲线下面积(area under the curve, AUC),评估Lp(a)、TyG指数单独及联合检测对术后非致命性心梗的预测效能。结果:非致命性心梗组患者的Lp(a)水平、TyG指数均显著高于无非致命性组(均P < 0.05),而两组患者强效他汀使用率无显著差异(P = 1.000)。多因素Cox回归分析显示,高Lp(a)水平(HR = 3.240, 95% CI: 2.237~4.692, P < 0.05)和高TyG指数(HR = 3.330, 95% CI: 2.297~4.829, P < 0.001)是CHD合并T2DM首次PCI术后发生非致命性心肌梗死的独立危险因素;同时高Lp(a)联合高TyG指数的患者术后发生非致命性心肌梗死的风险最高(HR = 13.380, 95% CI: 6.578~27.213, P < 0.001)。ROC曲线分析显示,Lp(a)、TyG指数及二者联合模型的AUC分别为0.626,0.657,0.727。TyG指数的AUC (0.657)显著高于HbA1c (0.538) (Z = 4.290, P < 0.001)。经Bootstrap 1000次重抽样验证,Lp(a)和TyG指数联合模型平均AUC为0.637 (95% CI: 0.575~0.701),提示模型稳定性良好。结论:Lp(a)、TyG指数与CHD合并T2DM患者首次PCI术后非致命性心肌梗死的发生显著相关,且二者联合检测的预测效能优于单一指标,经Bootstrap验证模型稳定性良好,可作为术后非致命性心肌梗死的有效预测指标。
Abstract: Objective: To explore the predictive value of lipoprotein(a) (Lp(a)) combined with the triglyceride-glucose (TyG) index for non-fatal myocardial infarction after the first percutaneous coronary intervention (PCI) in patients with coronary heart disease (CHD) with type 2 diabetes mellitus (T2DM). Methods: A retrospective analysis was conducted on the clinical data of 586 patients with CHD complicated by T2DM who underwent PCI for the first time at Qingdao University Hospital between January 2020 and January 2023. Patients were followed up postoperatively, and the occurrence of non-fatal myocardial infarction was recorded. Patients were categorized into a non-fatal MI group (n = 115) and a non-fatal MI-free group (n = 471) based on postoperative non-fatal MI occurrence. The use of high-intensity statins was compared between the two groups. Bootstrap resampling (1000 resamples) was employed to correct the AUC and 95% confidence interval of the receiver operating characteristic (ROC) curve to validate model stability. Glycated hemoglobin (HbA1c) was included as a control indicator. Multivariate Cox proportional hazards regression analysis was performed to identify risk factors for postoperative non-fatal myocardial infarction. ROC curves were plotted, and the area under the curve (AUC) was calculated to evaluate the predictive performance of Lp(a) and TyG index, both individually and in combination, for postoperative non-fatal myocardial infarction. Results: Patients in the non-fatal myocardial infarction group exhibited significantly higher Lp(a) levels and TyG indices compared to the non-non-fatal group (both P < 0.05), while there was no significant difference in the use of intensive statins between the two groups (P = 1.000). Multivariate Cox regression analysis revealed that elevated Lp(a) levels (HR = 3.240, 95% CI: 2.237~4.692, P < 0.05) and high TyG index (HR = 3.330, 95% CI: 2.297~4.829, P < 0.001) were independent risk factors for non-fatal myocardial infarction after initial PCI in patients with CHD and T2DM, while patients with both elevated Lp(a) and high TyG index exhibited the highest risk of postoperative non-fatal myocardial infarction (HR = 13.380, 95% CI: 6.578~27.213, P < 0.001). ROC curve analysis revealed AUC values of 0.626, 0.657, and 0.727 for Lp(a), TyG index, and the combined model, respectively. The TyG index AUC (0.657) was significantly higher than those of glycated hemoglobin (HbA1c) (0.538) (Z = 4.290, P < 0.001). Bootstrap resampling (n = 1000) validated the combined Lp(a) and TyG index model with a mean AUC of 0.637 (95% CI: 0.575~0.701), indicating good model stability. Conclusions: Lp(a) and TyG index are significantly correlated with the occurrence of non-fatal myocardial infarction in patients with CHD and T2DM after their first PCI procedure. The predictive performance of their combined detection is superior to that of either index alone. The model’s stability has been verified through Bootstrap analysis, indicating that it can serve as an effective predictor of non-fatal myocardial infarction after the procedure.
文章引用:陈雪, 李健. 脂蛋白(a)联合TyG指数对冠心病合并 2型糖尿病患者首次PCI术后非致命性 心肌梗死的预测价值[J]. 临床医学进展, 2026, 16(2): 1780-1791. https://doi.org/10.12677/acm.2026.162571

参考文献

[1] Virani, S.S., Newby, L.K., Arnold, S.V., Bittner, V., Brewer, L.C., Demeter, S.H., et al. (2023) 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients with Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 148, e9-e11. [Google Scholar] [CrossRef] [PubMed]
[2] Einarson, T.R., Acs, A., Ludwig, C. and Panton, U.H. (2018) Prevalence of Cardiovascular Disease in Type 2 Diabetes: A Systematic Literature Review of Scientific Evidence from across the World in 2007-2017. Cardiovascular Diabetology, 17, Article No. 83. [Google Scholar] [CrossRef] [PubMed]
[3] Bornfeldt, K.E. and Tabas, I. (2011) Insulin Resistance, Hyperglycemia, and Atherosclerosis. Cell Metabolism, 14, 575-585. [Google Scholar] [CrossRef] [PubMed]
[4] Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R.A., Antunes, M.J., et al. (2023) 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. European Heart Journal, 44, 4043-4140. [Google Scholar] [CrossRef] [PubMed]
[5] Lawton, J.S., Tamis-Holland, J.E., Bangalore, S., Bates, E.R., Beckie, T.M., Bischoff, J.M., et al. (2022) 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e4-e17. [Google Scholar] [CrossRef] [PubMed]
[6] Kronenberg, F., Mora, S., Stroes, E.S.G., Ference, B.A., Arsenault, B.J., Berglund, L., et al. (2022) Lipoprotein(a) in Atherosclerotic Cardiovascular Disease and Aortic Stenosis: A European Atherosclerosis Society Consensus Statement. European Heart Journal, 43, 3925-3946. [Google Scholar] [CrossRef] [PubMed]
[7] Berman, A.N., Biery, D.W., Besser, S.A., Singh, A., Shiyovich, A., Weber, B.N., et al. (2024) Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients with or without Baseline Atherosclerotic Cardiovascular Disease. Journal of the American College of Cardiology, 83, 873-886. [Google Scholar] [CrossRef] [PubMed]
[8] Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J. and Martínez, J.A. (2016) The Tyg Index May Predict the Development of Cardiovascular Events. European Journal of Clinical Investigation, 46, 189-197. [Google Scholar] [CrossRef] [PubMed]
[9] da Silva, A., Caldas, A.P.S., Hermsdorff, H.H.M., Bersch-Ferreira, Â.C., Torreglosa, C.R., Weber, B., et al. (2019) Triglyceride-Glucose Index Is Associated with Symptomatic Coronary Artery Disease in Patients in Secondary Care. Cardiovascular Diabetology, 18, Article No. 89. [Google Scholar] [CrossRef] [PubMed]
[10] Luo, T., Chen, S., Cai, J., Liu, Q., Gou, R., Mo, X., et al. (2022) Association between Combined Exposure to Plasma Heavy Metals and Dyslipidemia in a Chinese Population. Lipids in Health and Disease, 21, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
[11] ElSayed, N.A., McCoy, R.G., Aleppo, G., Balapattabi, K., Beverly, E.A., Briggs Early, K., et al. (2024) 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care, 48, S27-S49. [Google Scholar] [CrossRef] [PubMed]
[12] Fihn, S.D., Gardin, J.M., Abrams, J., Berra, K., Blankenship, J.C., Dallas, A.P., et al. (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation, 126, e354-e471. [Google Scholar] [CrossRef] [PubMed]
[13] Crengle, S. (2020) Comment On: Jaine Et Al Cost-Effectiveness of a Low-Dose Computed Tomography Screening Programme for Lung Cancer in New Zealand. Lung Cancer 2018, 124, 233-240. 2018/10/01. Lung Cancer, 145, 219-220. [Google Scholar] [CrossRef] [PubMed]
[14] Jiang, Z., Ruan, S., Duan, Q., Zhang, W. and Pan, S. (2025) Predictive Value of Lp(a) for MACE in ACS Patients with T2DM Following PCI, with Achieved LDL-C Target: A Cross-Sectional Study. Science Progress, 108, 1-12. [Google Scholar] [CrossRef] [PubMed]
[15] Xu, S., Qin, Z., Yuan, R., Cui, X., Zhang, L., Bai, J., et al. (2022) The Hemoglobin Glycation Index Predicts the Risk of Adverse Cardiovascular Events in Coronary Heart Disease Patients with Type 2 Diabetes Mellitus. Frontiers in Cardiovascular Medicine, 9, Article 992252. [Google Scholar] [CrossRef] [PubMed]
[16] Zhong, M., Tian, X., Sun, Q., Li, L., Lu, Y., Feng, Z., et al. (2023) Correlation of Asprosin and NRG-4 with Type 2 Diabetes Mellitus Complicated with Coronary Heart Disease and the Diagnostic Value. BMC Endocrine Disorders, 23, Articek No. 61. [Google Scholar] [CrossRef] [PubMed]
[17] Nurmohamed, N.S., Moriarty, P.M. and Stroes, E.S. (2022) Considerations for Routinely Testing for High Lipoprotein(a). Current Opinion in Lipidology, 34, 174-179. [Google Scholar] [CrossRef] [PubMed]
[18] Sagris, M., Antonopoulos, A.S., Theofilis, P., Oikonomou, E., Siasos, G., Tsalamandris, S., et al. (2021) Risk Factors Profile of Young and Older Patients with Myocardial Infarction. Cardiovascular Research, 118, 2281-2292. [Google Scholar] [CrossRef] [PubMed]
[19] Bittner, V.A., Szarek, M., Aylward, P.E., Bhatt, D.L., Diaz, R., Edelberg, J.M., et al. (2020) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk after Acute Coronary Syndrome. Journal of the American College of Cardiology, 75, 133-144. [Google Scholar] [CrossRef] [PubMed]
[20] Zeng, J., Li, N., Ma, C., Song, Y., Tian, W., Gao, Y., et al. (2025) Association between Triglyceride-Glucose Index and Postoperative Delirium Following Cardiac Surgery: A Multicenter Retrospective Analysis. Lipids in Health and Disease, 24, Article No. 330. [Google Scholar] [CrossRef
[21] Bulut, M., Celik, F.B., Guvenc, T.S., Yilmaz, Y., Celik, M., Ozyildirim, S., et al. (2024) Usefulness of Triglyceride-Glucose Index and Homeostatic Model Assessment for Predicting Coronary Microvascular Dysfunction. Journal of Clinical Lipidology, 18, e764-e772. [Google Scholar] [CrossRef] [PubMed]
[22] Tai, S., Fu, L., Zhang, N., Zhou, Y., Xing, Z. and Wang, Y. (2022) Impact of Baseline and Trajectory of Triglyceride-Glucose Index on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 13, Article 858209. [Google Scholar] [CrossRef] [PubMed]
[23] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[24] Vergès, B. (2015) Pathophysiology of Diabetic Dyslipidaemia: Where Are We? Diabetologia, 58, 886-899. [Google Scholar] [CrossRef] [PubMed]
[25] Reyes-Soffer, G., Ginsberg, H.N., Berglund, L., Duell, P.B., Heffron, S.P., Kamstrup, P.R., et al. (2022) Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 42, e48-e60. [Google Scholar] [CrossRef] [PubMed]
[26] van der Valk, F.M., Bekkering, S., Kroon, J., Yeang, C., Van den Bossche, J., van Buul, J.D., et al. (2016) Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans. Circulation, 134, 611-624. [Google Scholar] [CrossRef] [PubMed]